# Governance Record: v53c_insurance_pm_decision_v1

Date: 2026-07-17

Project:

```text
V5.3c Insurance Low-PB-only Formal Review
```

PM decision:

```text
research_pit_validation_passed_engineering_handoff_allowed
```

## Decision

Project Manager Agent approves V5.3c for Engineering Agent preparation.

This is not an accepted strategy. It is a formal research candidate that has passed the research PIT validation gate.

## Why

Research Agent narrowed the hypothesis correctly:

- score factor is only low PB;
- profit growth is removed;
- ROE is not a positive quality factor;
- dividend is only a reference baseline, not a composite input;
- real 10Y government yield is a review state variable, not a timing score.

Quant Validation Agent found enough evidence for engineering preparation:

- PIT leakage audit passed;
- low PB mean IC is positive;
- RankIC is positive;
- positive IC ratio is above 70%;
- low PB-only beats equal-weight insurance, high-dividend reference and V5.3b low-PB + dividend.

## Key Evidence

| Item | Value |
| --- | ---: |
| Low PB mean IC | 0.2004 |
| Low PB mean RankIC | 0.2023 |
| Positive IC ratio | 70.45% |
| Low PB-only cumulative return | 137.12% |
| Equal-weight insurance cumulative return | 79.01% |
| High-dividend reference cumulative return | 86.56% |
| V5.3b composite cumulative return | 114.17% |

## Risks That Block Final Acceptance

- 2021 and 2026 are still negative failure years.
- 2026 materially underperforms the full insurance universe.
- The 5-stock insurance universe creates high selection-count sensitivity.
- Top2 / Top3 results are much stronger than Top4 / Top5, so concentration may be a hidden driver.
- EV / NBV and solvency fields remain unrepaired.
- This validation is quarterly research PIT, not local daily execution proof.

## Engineering Handoff

Engineering Agent may now prepare:

- local daily backtest runner for V5.3c;
- insurance-specific benchmark choice;
- rebalance signal generation;
- holdings, cash, trade and daily-return logs;
- execution-price and dividend-treatment audit;
- platform-replication readiness packet.

Engineering Agent must not:

- write JoinQuant code before local daily simulation and benchmark policy are approved;
- label V5.3c as accepted;
- tune the rule on 2021-2026 platform comparison results.

## Next Gate

```text
engineering_local_daily_simulation_preparation
```

